Evaluation of second-line treatment options in non-small cell lung cancer - Introduction

被引：1
作者：
Scagliotti, GV [1 ]
机构：
[1] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
来源：
SEMINARS IN ONCOLOGY | 2006年 / 33卷 / 01期
关键词：
D O I：
10.1053/j.seminoncol.2005.12.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1 / S2
页数：2
相关论文
共 50 条
  • [21] Considerations for second-line therapy of non-small cell lung cancer
    Stinchcombe, Thomas E.
    Socinski, Mark A.
    ONCOLOGIST, 2008, 13 : 28 - 36
  • [22] Advanced non-small cell lung cancer. Maintenance and second-line treatment
    Schuette, W.
    Nagel, S.
    Haak, G.
    Steinert, M.
    PNEUMOLOGE, 2012, 9 (01): : 43 - 48
  • [23] Second-Line Chemotherapy and Beyond for Non-Small Cell Lung Cancer
    Durm, Greg
    Hanna, Nasser
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 71 - +
  • [24] SECOND-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Cullen, M.
    LUNG CANCER, 2009, 64 : S13 - S13
  • [25] Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer
    J. Feliu
    G. Martín
    J. Castro
    A. Sundlov
    A. Rodriguez-Jaráiz
    E. Casado
    M. Lomas
    C. Madroñal
    A. Galán
    C. Belda
    M. Gonzalez-Barón
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 527 - 531
  • [26] Influence of Radiotherapy in Second-Line Treatment with Immunotherapy in Patients with Non-Small Cell Lung Cancer
    Azkona, E.
    Carrera, S.
    Rubio, I.
    Mane, J. M.
    Lacambra, I.
    Sancho, A.
    Novo, E.
    Lopez-Vivanco, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S969 - S969
  • [27] Biweekly Vinorelbine and Gemcitabine as Second-Line Treatment and Beyond in Non-Small Cell Lung Cancer
    Chelis, L.
    Xenidis, N.
    Amarantidis, K.
    Prassopoulos, P.
    Chamalidou, E.
    Neanidis, K.
    Mikroulis, D.
    Chatzaki, E.
    Karakitsos, P.
    Kakolyris, S.
    CHEMOTHERAPY, 2010, 56 (05) : 353 - 358
  • [28] Weekly docetaxel as a second-line treatment for advanced non-small cell lung cancer (NSCLC).
    García, R
    Pérez, P
    Alfonso, R
    Pérez-Manga, G
    Díaz-Rubio, E
    ANNALS OF ONCOLOGY, 2000, 11 : 116 - 116
  • [29] Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib
    Zugazagoitia, Jon
    Diaz, Asuncion
    Jimenez, Elisabeth
    Nunez, Juan Antonio
    Iglesias, Lara
    Ponce-Aix, Santiago
    Paz-Ares, Luis
    FRONTIERS IN MEDICINE, 2017, 4
  • [30] Docetaxel as Second-line Monotherapy for Advanced Non-small Cell Lung Cancer
    Kang, Hyun Mo
    Lee, Jeong Eun
    Jang, Pil Soon
    Lee, Yun Sun
    Kwon, Sun Jung
    An, Jin Young
    Jung, Sung Soo
    Kim, Ju Ock
    Kim, Sun Young
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 58 (05) : 465 - 472
12345